Agentix (AGTX) Profit After Tax (2013 - 2026)
Agentix's (AGTX) quarterly Profit After Tax came in at -$82848.0 in Q1 2026, up 60.65% YoY from -$51571.4 in Q1 2025, and down 3.61% on a QoQ basis from -$79962.0 in Q4 2025.
Agentix (AGTX) Profit After Tax (2013 - 2026) Analysis & Trends
Agentix (AGTX) has 14 years of Profit After Tax data on file, last reported at -$82848.0 in Q1 2026.
- Quarterly Profit After Tax rose 60.65% year-over-year to -$82848.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$474434.0 (up 24.81% YoY) and the FY2026 annual result came in at -$476599.0, up 15.95% from the prior year.
- Profit After Tax retreated to -$82848.0 in Q1 2026, from -$79962.0 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $8597.0 in Q1 2024 to a low of -$2.0 million in Q1 2022.
- A 5-year average of -$300367.4 and a median of -$165780.0 in 2024 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2024 — Profit After Tax surged 102.0% — and 2025, when it slumped 2548.84%.
- Tracing AGTX's Profit After Tax over 5 years: stood at -$353638.0 in 2022, then jumped by 91.37% to -$30515.0 in 2023, then slumped by 371.55% to -$143894.0 in 2024, then soared by 44.43% to -$79962.0 in 2025, then fell by 3.61% to -$82848.0 in 2026.
- The last three Profit After Tax figures came in at -$82848.0 (Q1 2026), -$79962.0 (Q4 2025), and -$144107.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.62 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Agentix | 801,339.00 | 801,301.00 | - | -118,282.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -118,282.00 |
| Mar 31, 2026 | -82,848.00 |
| Dec 31, 2025 | -79,962.00 |
| Sep 30, 2025 | -144,107.00 |
| Jun 30, 2025 | -167,517.00 |
| Mar 31, 2025 | -210,527.00 |
| Dec 31, 2024 | -143,894.00 |
| Sep 30, 2024 | -110,774.00 |
| Jun 30, 2024 | -165,780.00 |
| Mar 31, 2024 | 8,597.00 |
| Dec 31, 2023 | -30,515.00 |
| Sep 30, 2023 | -178,972.00 |
| Jun 30, 2023 | -409,558.00 |
| Mar 31, 2023 | -430,418.00 |
| Dec 31, 2022 | -353,638.00 |
| Sep 30, 2022 | -424,330.00 |
| Jun 30, 2022 | -164,654.00 |
| Feb 28, 2022 | -2.02 Mn |
| Nov 30, 2021 | -166,750.00 |
| Aug 31, 2021 | -243,426.00 |